Genomic Profiling of Advanced-Stage Oral Cancers Reveals Chromosome 11q Alterations as Markers of Poor Clinical Outcome
2011

Genomic Profiling of Advanced-Stage Oral Cancers

Sample size: 60 publication Evidence: high

Author Information

Author(s): Ambatipudi Srikant, Gerstung Moritz, Gowda Ravindra, Pai Prathamesh, Borges Anita M., Schäffer Alejandro A., Beerenwinkel Niko, Mahimkar Manoj B.

Primary Institution: Tata Memorial Centre (TMC), Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, India

Hypothesis

Can genomic alterations in advanced-stage oral cancers provide prognostic information?

Conclusion

The study identifies specific genomic alterations that may serve as biological markers for prognosis and treatment decisions in oral cancers.

Supporting Evidence

  • Copy-number changes were observed on chromosomal arms with frequent gains on 3q, 5p, 7p, 8q, and 11q.
  • Losses were noted on 3p14.2 and 8p, with significant associations found for specific chromosomal alterations.
  • The gain of 11q22 and loss of 11q23-q25 were validated by interphase fluorescent in situ hybridization.

Takeaway

This study looked at changes in the DNA of patients with advanced oral cancer to find clues about how likely they are to get better or worse.

Methodology

High-resolution array comparative genomic hybridization was performed on tumor samples to identify genomic alterations.

Limitations

The study focused only on advanced-stage cancers and may not be generalizable to all oral cancers.

Participant Demographics

The cohort consisted of 60 patients, predominantly male (80%), with a mean age of 53 years.

Statistical Information

P-Value

P=0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017250

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication